<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Treatment protocols for non-small cell lung cancer
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Treatment protocols for non-small cell lung cancer
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Treatment protocols for non-small cell lung cancer
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Tim Brenner, PharmD, BCOP
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Shrina Duggal, PharmD, BCOP
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jim Natale, PharmD, BCOP
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Steven E Schild, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sadhna R Vora, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Nov 06, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H6926423">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The following material represents a subset of chemotherapy and immunotherapy regimens that are used for the treatment of patients with non-small cell lung cancer.
         <strong>
          This is
         </strong>
         <strong>
          not an exhaustive list
         </strong>
         ; it includes regimens that are considered by the authors and editors to be commonly used and important for the care of patients with non-small cell lung cancer. Additional regimens may be added over time, particularly as treatment for non-small cell lung cancer evolves.
        </p>
        <p>
         This topic review is intended to provide only a listing of chemotherapy and immunotherapy regimens. It does not address the appropriate context for use of these regimens in the care of patients with non-small cell lung cancer. Clinicians should refer to the individual disease-oriented topic reviews that discuss the use of these protocols in appropriate clinical situations:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/90312.html" rel="external">
          "Initial management of advanced non-small cell lung cancer lacking a driver mutation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4629.html" rel="external">
          "Subsequent line therapy in non-small cell lung cancer lacking a driver mutation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4636.html" rel="external">
          "Systemic therapy in resectable non-small cell lung cancer"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         These tables are provided as examples of how to administer these regimens; there may be other acceptable methods. All chemotherapy and immunotherapy regimens must be administered by clinicians who are trained in the use of chemotherapy and immunotherapy. The clinician is expected to use his or her independent medical judgment in the context of individual circumstances to make adjustments, as necessary.
        </p>
        <p class="headingAnchor" id="H119318348">
         <span class="h1">
          REGIMENS
         </span>
        </p>
        <p class="headingAnchor" id="H936242762">
         <span class="h2">
          Carboplatin plus docetaxel
         </span>
         <span class="headingEndMark">
          —
         </span>
         (
         <a class="graphic graphic_table graphicRef69824" href="/z/d/graphic/69824.html" rel="external">
          table 1
         </a>
         )
        </p>
        <p class="headingAnchor" id="H112737105">
         <span class="h2">
          Carboplatin plus nanoparticle albumin-bound paclitaxel (nabpaclitaxel)
         </span>
         <span class="headingEndMark">
          —
         </span>
         (
         <a class="graphic graphic_table graphicRef95755" href="/z/d/graphic/95755.html" rel="external">
          table 2
         </a>
         )
        </p>
        <p class="headingAnchor" id="H1039625715">
         <span class="h2">
          Carboplatin, paclitaxel, atezolizumab, and bevacizumab
         </span>
         <span class="headingEndMark">
          —
         </span>
         (
         <a class="graphic graphic_table graphicRef131711" href="/z/d/graphic/131711.html" rel="external">
          table 3
         </a>
         )
        </p>
        <p class="headingAnchor" id="H936242787">
         <span class="h2">
          Carboplatin plus pemetrexed
         </span>
         <span class="headingEndMark">
          —
         </span>
         (
         <a class="graphic graphic_table graphicRef81778" href="/z/d/graphic/81778.html" rel="external">
          table 4
         </a>
         )
        </p>
        <p class="headingAnchor" id="H936242837">
         <span class="h2">
          Cisplatin plus pemetrexed
         </span>
         <span class="headingEndMark">
          —
         </span>
         (
         <a class="graphic graphic_table graphicRef67209" href="/z/d/graphic/67209.html" rel="external">
          table 5
         </a>
         )
        </p>
        <p class="headingAnchor" id="H936242862">
         <span class="h2">
          Gemcitabine plus carboplatin
         </span>
         <span class="headingEndMark">
          —
         </span>
         (
         <a class="graphic graphic_table graphicRef54959" href="/z/d/graphic/54959.html" rel="external">
          table 6
         </a>
         )
        </p>
        <p class="headingAnchor" id="H936242887">
         <span class="h2">
          Gemcitabine plus cisplatin (GC)
         </span>
         <span class="headingEndMark">
          —
         </span>
         (
         <a class="graphic graphic_table graphicRef64774" href="/z/d/graphic/64774.html" rel="external">
          table 7
         </a>
         )
        </p>
        <p class="headingAnchor" id="H936242937">
         <span class="h2">
          Paclitaxel carboplatin
         </span>
         <span class="headingEndMark">
          —
         </span>
         (
         <a class="graphic graphic_table graphicRef56125" href="/z/d/graphic/56125.html" rel="external">
          table 8
         </a>
         )
        </p>
        <p class="headingAnchor" id="H936242912">
         <span class="h2">
          Paclitaxel, carboplatin, and bevacizumab
         </span>
         <span class="headingEndMark">
          —
         </span>
         (
         <a class="graphic graphic_table graphicRef76013" href="/z/d/graphic/76013.html" rel="external">
          table 9
         </a>
         )
        </p>
        <p class="headingAnchor" id="H341361729">
         <span class="h2">
          Pembrolizumab monotherapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         (
         <a class="graphic graphic_table graphicRef127101" href="/z/d/graphic/127101.html" rel="external">
          table 10
         </a>
         )
        </p>
        <p class="headingAnchor" id="H1970867679">
         <span class="h2">
          Pembrolizumab, nabpaclitaxel, and carboplatin
         </span>
         <span class="headingEndMark">
          —
         </span>
         (
         <a class="graphic graphic_table graphicRef123117" href="/z/d/graphic/123117.html" rel="external">
          table 11
         </a>
         )
        </p>
        <p class="headingAnchor" id="H351154137">
         <span class="h2">
          Pembrolizumab, paclitaxel, and carboplatin
         </span>
         <span class="headingEndMark">
          —
         </span>
         (
         <a class="graphic graphic_table graphicRef122978" href="/z/d/graphic/122978.html" rel="external">
          table 12
         </a>
         )
        </p>
        <p class="headingAnchor" id="H4055639121">
         <span class="h2">
          Pembrolizumab, pemetrexed, and carboplatin
         </span>
         <span class="headingEndMark">
          —
         </span>
         (
         <a class="graphic graphic_table graphicRef122970" href="/z/d/graphic/122970.html" rel="external">
          table 13
         </a>
         )
        </p>
        <p class="headingAnchor" id="H1976644369">
         <span class="h2">
          Nivolumab monotherapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         (
         <a class="graphic graphic_table graphicRef127100" href="/z/d/graphic/127100.html" rel="external">
          table 14
         </a>
         )
        </p>
        <p class="headingAnchor" id="H936242962">
         <span class="h2">
          Vinorelbine plus cisplatin
         </span>
         <span class="headingEndMark">
          —
         </span>
         (
         <a class="graphic graphic_table graphicRef59705" href="/z/d/graphic/59705.html" rel="external">
          table 15
         </a>
         )
        </p>
        <p class="headingAnchor" id="H695509742">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/112231.html" rel="external">
          "Society guideline links: Diagnosis and management of lung cancer"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1469784125">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Scott M Wirth, PharmD, BCOP, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div id="topicVersionRevision">
        Topic 85689 Version 29.0
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
